Iain S McGregor

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 17

Top Venues

Psychopharmacology

BMJ open

Drug testing and analysis

International journal of clinical pharmacy

University of Sydney

University of Sydney (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Sydney Jul 01 2016

Australia

Academic Director :: Lambert Initiative for Cannabinoid Therapeutics

University of Sydney Jan 01 2006

Australia

Professor of Psychopharmacology :: School of Psychology

Education History

University of Sydney

Australia

PHD :: School of Psychology

Publications

Zeeta Bawa, Danielle McCartney, Miguel Bedoya-Pérez, Namson S Lau, Richard Fox, Hamish MacDougall, Iain S McGregor
Effects of cannabidiol on psychosocial stress, situational anxiety and nausea in a virtual reality environment: a protocol for a single-centre randomised clinical trial. BMJ open 14 (3) (2024)
Anastasia Suraev, Danielle McCartney, Nathaniel S Marshall, Christopher Irwin, Ryan Vandrey, Ronald R Grunstein, Angela L D'Rozario, Christopher Gordon, Delwyn Bartlett, Camilla M Hoyos, Iain S McGregor
Evaluating possible 'next day' impairment in insomnia patients administered an oral medicinal cannabis product by night: a pilot randomized controlled trial. Psychopharmacology 241 (9) (2024)
Anastasia Suraev, Danielle McCartney, Nathaniel S Marshall, Christopher Irwin, Ryan Vandrey, Ronald R Grunstein, Angela L D'Rozario, Christopher Gordon, Delwyn Bartlett, Camilla M Hoyos, Iain S McGregor
Evaluating possible 'next day' impairment in insomnia patients administered an oral medicinal cannabis product by night: a pilot randomized controlled trial. Psychopharmacology (2024)
Anastasia Suraev, Danielle McCartney, Nathaniel S Marshall, Christopher Irwin, Ryan Vandrey, Ronald R Grunstein, Angela L D'Rozario, Christopher Gordon, Delwyn Bartlett, Camilla M Hoyos, Iain S McGregor
Evaluating possible 'next day' impairment in insomnia patients administered an oral medicinal cannabis product by night: a pilot randomized controlled trial. Psychopharmacology 241 (9) (2024)
Zeeta Bawa, Danielle McCartney, Miguel Bedoya-Pérez, Namson S Lau, Richard Fox, Hamish MacDougall, Iain S McGregor
Effects of cannabidiol on psychosocial stress, situational anxiety and nausea in a virtual reality environment: a protocol for a single-centre randomised clinical trial. BMJ open 14 (3) (2024)
Anastasia Suraev, Danielle McCartney, Nathaniel S Marshall, Christopher Irwin, Ryan Vandrey, Ronald R Grunstein, Angela L D'Rozario, Christopher Gordon, Delwyn Bartlett, Camilla M Hoyos, Iain S McGregor
Evaluating possible 'next day' impairment in insomnia patients administered an oral medicinal cannabis product by night: a pilot randomized controlled trial. Psychopharmacology 241 (9) (2024)
Zeeta Bawa, Danielle McCartney, Miguel Bedoya-Pérez, Namson S Lau, Richard Fox, Hamish MacDougall, Iain S McGregor
Effects of cannabidiol on psychosocial stress, situational anxiety and nausea in a virtual reality environment: a protocol for a single-centre randomised clinical trial. BMJ open 14 (3) (2024)
Anastasia Suraev, Danielle McCartney, Nathaniel S Marshall, Christopher Irwin, Ryan Vandrey, Ronald R Grunstein, Angela L D'Rozario, Christopher Gordon, Delwyn Bartlett, Camilla M Hoyos, Iain S McGregor
Evaluating possible 'next day' impairment in insomnia patients administered an oral medicinal cannabis product by night: a pilot randomized controlled trial. Psychopharmacology 241 (9) (2024)
Jonathon C Arnold, Danielle McCartney, Anastasia Suraev, Iain S McGregor
The safety and efficacy of low oral doses of cannabidiol: An evaluation of the evidence. Clinical and translational science (2022)
Zeeta Bawa, Bandana Saini, Danielle McCartney, Miguel Bedoya-Pérez, Andrew J McLachlan, Iain S McGregor
A cross-sectional survey exploring the knowledge, experiences and attitudes of Australian pharmacists toward medicinal cannabis. International journal of clinical pharmacy (2022)
Miguel A Bedoya-Pérez, Michael P Ward, Max Loomes, Iain S McGregor, Mathew S Crowther
The effect of COVID19 pandemic restrictions on an urban rodent population. Scientific reports 11 (1) (2021)
Thomas R Arkell, Richard C Kevin, Frederick Vinckenbosch, Nicholas Lintzeris, Eef Theunissen, Johannes G Ramaekers, Iain S McGregor
Sex differences in acute cannabis effects revisited: Results from two randomized, controlled trials. Addiction biology 27 (2) (2021)
Richard C Kevin, Rebecca Vogel, Peter Doohan, Maximus Berger, G Paul Amminger, Iain S McGregor
A validated method for the simultaneous quantification of cannabidiol, Δ9 -tetrahydrocannabinol, and their metabolites in human plasma and application to plasma samples from an oral cannabidiol open-label trial. Drug testing and analysis 13 (3) (2020)
Danielle McCartney, Ashling D Isik, Kieron B Rooney, Jonathon C Arnold, Delwyn J Bartlett, Bridin Murnion, Elisha Richards, Thomas R Arkell, Nicholas Lintzeris, Iain S McGregor
The effect of daily aerobic cycling exercise on sleep quality during inpatient cannabis withdrawal: A randomised controlled trial. Journal of sleep research 30 (3) (2020)
Thomas R Arkell, Richard C Kevin, Jordyn Stuart, Nicholas Lintzeris, Paul S Haber, Johannes G Ramaekers, Iain S McGregor
Detection of Δ9 THC in oral fluid following vaporized cannabis with varied cannabidiol (CBD) content: An evaluation of two point-of-collection testing devices. Drug testing and analysis 11 (10) (2019)
Thomas R Arkell, Nicholas Lintzeris, Richard C Kevin, Johannes G Ramaekers, Ryan Vandrey, Christopher Irwin, Paul S Haber, Iain S McGregor
Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition. Psychopharmacology 236 (9) (2019)
Samuel D Banister, Axel Adams, Richard C Kevin, Christa Macdonald, Michelle Glass, Rochelle Boyd, Mark Connor, Iain S McGregor, Christopher M Havel, Stephen J Bright, Mireia Ventura Vilamala, Cristina Gil Lladanosa, Monica J Barratt, Roy R Gerona
Synthesis and pharmacology of new psychoactive substance 5F-CUMYL-P7AICA, a scaffold- hopping analog of synthetic cannabinoid receptor agonists 5F-CUMYL-PICA and 5F-CUMYL-PINACA. Drug testing and analysis 11 (2) (2018)

Iain S McGregor.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Iain S McGregor